Cosmo Bio Company,Limited (3386.T)
JPY 1130.0
(0.0%)
JPY 1130.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 9.34 Billion | 9.55 Billion | 9.23 Billion | 8.09 Billion | 7.59 Billion |
| Cost of Revenue | 6.09 Billion | 6.11 Billion | 5.57 Billion | 4.94 Billion | 4.71 Billion |
| Gross Profit | 3.25 Billion | 3.44 Billion | 3.65 Billion | 3.15 Billion | 2.88 Billion |
| Operating Expenses | 2.73 Billion | 2.62 Billion | 2.6 Billion | 2.39 Billion | 2.53 Billion |
| Selling, General and Administrative Expenses | 2.72 Billion | 2.62 Billion | 2.6 Billion | 2.39 Billion | 2.47 Billion |
| Research and Development Expenses | 73 Million | 82 Million | 70 Million | 80 Million | 81 Million |
| Other Expenses | -71 Million | 6 Million | 25 Million | 32 Million | - |
| Cost and Expenses | 8.82 Billion | 8.73 Billion | 8.18 Billion | 7.33 Billion | 7.24 Billion |
| Operating Income | 519 Million | 816 Million | 1.04 Billion | 752 Million | 406 Million |
| Interest Expense | - | - | - | - | - |
| Income Tax Expense | 191 Million | 238 Million | 330 Million | 307 Million | 142 Million |
| Earnings before Tax | 653 Million | 790 Million | 1.09 Billion | 1 Billion | 387 Million |
| Net Income | 442 Million | 517 Million | 737 Million | 674 Million | 237 Million |
| Earnings Per Share Basic | 75.83 | 89.13 | 126.94 | 113.70 | 39.98 |
| Earnings Per Share Diluted | 75.83 | 89.13 | 126.94 | 113.70 | 39.98 |
| Weighted Average Shares Outstanding | 5.82 Million | 5.8 Million | 5.8 Million | 5.92 Million | 5.92 Million |
| Weighted Average Shares Outstanding (Diluted) | 5.82 Million | 5.8 Million | 5.8 Million | 5.92 Million | 5.92 Million |
| Gross Margin | 0.35 | 0.36 | 0.40 | 0.39 | 0.38 |
| EBIT Margin | 0.07 | 0.10 | 0.14 | 0.12 | 0.08 |
| Profit Margin | 0.05 | 0.05 | 0.08 | 0.08 | 0.03 |
| EBITDA | 669 Million | 958 Million | 1.21 Billion | 928 Million | 613 Million |
| Earnings Before Tax Margin | 0.06 | 0.09 | 0.11 | 0.09 | 0.05 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 2.18 Billion | 2.94 Billion | 2.46 Billion | 9.34 Billion | 2.05 Billion | 1.99 Billion |
| Cost of Revenue | 1.46 Billion | 1.95 Billion | 1.67 Billion | 6.09 Billion | 1.35 Billion | 1.27 Billion |
| Gross Profit | 726 Million | 987 Million | 785 Million | 3.25 Billion | 700 Million | 726 Million |
| Operating Expenses | 708 Million | 681 Million | 712 Million | 2.72 Billion | 711 Million | 668 Million |
| Selling, General and Administrative Expenses | 688 Million | 681 Million | 712 Million | - | 711 Million | 668 Million |
| Research and Development Expenses | 20 Million | 13 Million | 73 Million | - | 19 Million | 22 Million |
| Other Expenses | 3 Million | 3 Million | -1 Million | 6 Million | - | 3 Million |
| Cost and Expenses | 2.16 Billion | 2.63 Billion | 2.39 Billion | 8.81 Billion | 2.06 Billion | 1.94 Billion |
| Operating Income | 18 Million | 305 Million | 72 Million | 519 Million | -11 Million | 58 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 11 Million | 112 Million | 15 Million | 191 Million | 2 Million | 37 Million |
| Earnings before Tax | 37 Million | 353 Million | 99 Million | 653 Million | 2 Million | 136 Million |
| Net Income | 28 Million | 230 Million | 76 Million | 442 Million | 5 Million | 97 Million |
| Earnings Per Share Basic | 4.78 | 39.56 | 13.02 | - | 0.86 | 16.64 |
| Earnings Per Share Diluted | 4.78 | 39.56 | 13.02 | - | 0.86 | 16.64 |
| Weighted Average Shares Outstanding | 5.85 Million | 5.83 Million | 5.83 Million | 5.82 Million | 5.83 Million | 5.82 Million |
| Weighted Average Shares Outstanding (Diluted) | 5.85 Million | 5.83 Million | 5.83 Million | 5.82 Million | 5.83 Million | 5.82 Million |
| Gross Margin | 0.33 | 0.34 | 0.32 | 0.35 | 0.34 | 0.36 |
| EBIT Margin | 0.02 | 0.10 | 0.04 | - | -0.00 | 0.04 |
| Profit Margin | 0.01 | 0.08 | 0.03 | 0.05 | 0.00 | 0.05 |
| EBITDA | 50 Million | 295 Million | 98 Million | - | -7 Million | 84 Million |
| Earnings Before Tax Margin | 0.01 | 0.10 | 0.03 | 0.06 | -0.01 | 0.03 |
CULT
002641
BK
RAC
VICO
MND